EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

USP38 regulates inflammatory cardiac remodeling after myocardial infarction

Yang Gong, Bin Kong, Wei Shuai, Tao Chen, Jing Jing Zhang, He Huang iD

Clinical Science · 15.11.2023 · 137 (21) · 1665-1681

DOI: 10.1042/cs20230728 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 15.11.2023. Verfasst von Yang Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, Hubei 430060, China. Hauptthemen laut MEDLINE: NF-kappa B, Myocardial Infarction. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOST | National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The inflammatory response and subsequent ventricular remodeling are key factors contributing to ventricular arrhythmias (VAs) after myocardial infarction (MI). Ubiquitin-specific protease 38 (USP38) is a member of the USP family, but the impact of USP38 in arrhythmia substrate generation after MI remains unclear. This study aimed to determine the role of USP38 in post-MI VAs and its underlying mechanisms. Methods and results: Surgical left descending coronary artery ligation was used to construct MI models. Morphological, biochemical, histological, and electrophysiological studies and molecular analyses were performed after MI on days 3 and 28. We found that the USP38 expression was remarkably increased after MI. Cardiac-conditional USP38 knockout (USP38-CKO) reduces the expression of the inflammatory marker CD68 as well as the inflammatory factors TNF-α and IL-1β after MI, thereby alleviating advanced cardiac fibrosis, electrical remodeling, ion channel remodeling, and susceptibility to VAs. In contrast, cardiac-specific USP38 overexpression (USP38-TG) showed a significant opposite effect, exacerbating the early inflammatory response and cardiac remodeling after MI. Mechanistically, USP38 knockout inhibited activation of the TAK1/NF-κB signaling pathway after MI, whereas USP38 overexpression enhanced activation of the TAK1/NF-κB signaling pathway after MI.

Conclusions

Our study confirms that USP38-CKO attenuates the inflammatory response, improves ventricular remodeling after myocardial infarction, and reduces susceptibility to malignant VA by inhibiting the activation of the TAK1/NF-κB pathway, with USP38-TG playing an opposing role. These results suggest that USP38 may be an important target for the treatment of cardiac remodeling and arrhythmias after MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BMyocardial InfarctionHumansAnimalsVentricular RemodelingHeartSignal TransductionDisease Models, AnimalUbiquitin-Specific Proteases

Stichwörter der Autor:innen

cardiac arrhythmiainflammationmyocardial remodeling

Substanzen

NF-kappa BUSP38 protein, humanUbiquitin-Specific Proteases

Autor:innen und Institutionen

  • Department of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, Hubei 430060, China.
  • Cardiovascular Research Institute of Wuhan University, Wuhan, China.
  • Hubei Key Laboratory of Cardiology, Wuhan, China.

ORCID-Profile: He Huang

Förderung

  • MOST | National Natural Science Foundation of China

Zitieren

APA

Gong, Y., Kong, B., Shuai, W., Chen, T., Zhang, J. J., & Huang, H. (2023). USP38 regulates inflammatory cardiac remodeling after myocardial infarction. Clinical Science, 137(21), 1665-1681. https://doi.org/10.1042/cs20230728

Vancouver

Gong Y, Kong B, Shuai W, Chen T, Zhang JJ, Huang H. USP38 regulates inflammatory cardiac remodeling after myocardial infarction. Clinical Science. 2023;137(21):1665-1681. doi:10.1042/cs20230728

BibTeX
@article{Gong2023,
  author = {Gong, Yang and Kong, Bin and Shuai, Wei and Chen, Tao and Zhang, Jing Jing and Huang, He},
  title = {USP38 regulates inflammatory cardiac remodeling after myocardial infarction},
  journal = {Clinical Science},
  year = {2023},
  volume = {137},
  number = {21},
  pages = {1665--1681},
  doi = {10.1042/cs20230728}
}
Kostenlos starten →